Back to GetFilings.com




QuickLinks -- Click here to rapidly navigate through this document

United States
Securities and Exchange Commission
Washington, D.C. 20549


FORM 10-Q

Quarterly Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

For the Period Ended September 30, 2002

Commission File Number 1-14177

COBALT CORPORATION
(Exact name of registrant as specified in its charter)

Wisconsin
(State of incorporation)
39-1931212
(I.R.S. Employer Identification No.)

401 West Michigan Street, Milwaukee, Wisconsin
(Address of principal executive offices)

53203-2896
(Zip Code)

(414) 226-6900
(Registrant's telephone number, including area code)

        Indicate by check mark whether registrant (1) has filed all documents and reports required to be filed by Section 13, or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ý    No o

        Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practical date:

        Common stock outstanding as of October 31, 2002 was 41,522,369





COBALT CORPORATION

INDEX TO
QUARTERLY REPORT ON FORM 10-Q

For the Period Ended September 30, 2002

PART I    

Item 1. Financial Statements and Supplementary Data

 

3

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

 

18

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

29

Item 4. Controls and Procedures

 

29

PART II

 

 

Other Information

 

31

Signature Page

 

32

Certifications

 

33

2



PART I. FINANCIAL INFORMATION

Item 1. Financial Statements


COBALT CORPORATION
CONSOLIDATED BALANCE SHEETS
(UNAUDITED)

 
  September 30,
2002

  December 31,
2001

 
  (In thousands)

ASSETS            

Current assets:

 

 

 

 

 

 
 
Cash and cash equivalents

 

$

63,179

 

$

51,669
  Investments—available-for-sale, at fair value     347,121     180,692
  Due from affiliates     6,417     5,091
  Premium receivables     37,374     33,486
  Due from clinics and providers     4,219     11,922
  Other receivables     52,177     49,138
  Prepaid expenses and other current assets     30,488     30,150
   
 
    Total current assets     540,975     362,148

Noncurrent assets:

 

 

 

 

 

 
 
Investments—held-to-maturity, at amortized cost

 

 

12,688

 

 

11,007
  Investments in affiliates, net     471     79,466
  Property and equipment, net     30,526     31,411
  Goodwill, net     91,295     92,066
  Prepaid pension     58,557     53,837
  Deferred income taxes     37,868     29,385
  Other noncurrent assets     74,424     48,685

Assets from discontinued operations

 

 


 

 

19,317
   
 

Total assets

 

$

846,804

 

$

727,322
   
 

See Notes to Interim Consolidated Financial Statements.

3



COBALT CORPORATION
CONSOLIDATED BALANCE SHEETS
(UNAUDITED)

 
  September 30,
2002

  December 31,
2001

 
 
  (In thousands)

 
LIABILITIES AND SHAREHOLDERS' EQUITY              

Current liabilities:

 

 

 

 

 

 

 
 
Medical and other benefits payable

 

$

195,929

 

$

220,038

 
  Advance premiums     100,569     88,495  
  Due to affiliates     35     59  
  Payables and accrued expenses     71,226     49,582  
  Short-term debt     3,425     12,369  
  Other current liabilities     42,707     29,521  
   
 
 
    Total current liabilities     413,891     400,064  

Noncurrent liabilities:

 

 

 

 

 

 

 
 
Other benefits payable

 

 

53,734

 

 

47,282

 
  Deferred income taxes     34,505     29,259  
  Postretirement benefits other than pension     17,930     18,005  
  Long-term debt     25,000     3,000  
  Other noncurrent liabilities     16,480     16,421  

Liabilities from discontinued operations

 

 


 

 

5,069

 
   
 
 
   
Total liabilities

 

 

561,540

 

 

519,100

 

Shareholders' equity (Note K):

 

 

 

 

 

 

 
 
Preferred stock

 

 


 

 


 
  Common stock     259,309     249,566  
  Retained earnings (deficit)     18,291     (41,979 )
  Accumulated other comprehensive income     7,664     635  
   
 
 
    Total shareholders' equity     285,264     208,222  
   
 
 
Total liabilities and shareholders' equity   $ 846,804   $ 727,322  
   
 
 

See Notes to Interim Consolidated Financial Statements.

4



COBALT CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)

 
  Three months ended
September 30,

  Nine months ended
September 30,

 
 
  2002
  2001
  2002
  2001
 
 
  (In thousands, except share data)

 
Revenues:                          
  Health services revenue:                          
    Premium   $ 344,737   $ 369,726   $ 1,021,832   $ 886,631  
    Government contract fees     28,375     32,817     85,155     88,827  
    Other     12,579     10,830     35,993     30,073  
  Investment results     4,701     3,466     11,263     9,020  
   
 
 
 
 
      Total revenues     390,392     416,839     1,154,243     1,014,551  

Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 
  Medical and other benefits     293,805     332,723     876,971     793,913  
  Selling, general, administrative and other     81,012     83,065     238,461     219,115  
  Interest     116     234     359     441  
  Amortization of goodwill         1,530         3,231  
   
 
 
 
 
      Total expenses     374,933     417,552     1,115,791     1,016,700  
   
 
 
 
 

Operating income (loss) from continuing operations

 

 

15,459

 

 

(713

)

 

38,452

 

 

(2,149

)
Income from investment in affiliates, net of tax     3     1,581     15,320     388  
   
 
 
 
 
Pretax income (loss) from continuing operations     15,462     868     53,772     (1,761 )
Income tax expense     1,574     175     3,878     193  
   
 
 
 
 
Income (loss) from continuing operations     13,888     693     49,894     (1,954 )
Income from discontinued operations:                          
  Income (loss) from discontinued operations, net of tax     (130 )   364     (680 )   499  
  Gain (loss) on sale of discontinued operations, net of tax     (41 )       9,618      
   
 
 
 
 
Net income (loss)   $ 13,717   $ 1,057   $ 58,832   $ (1,455 )
   
 
 
 
 

Earnings (loss) per share (EPS):

 

 

 

 

 

 

 

 

 

 

 

 

 
  Basic EPS from continuing operations   $ 0.34   $ 0.02   $ 1.22   $ (0.05 )
  Basic EPS from discontinued operations     (0.01 )   0.01     0.22     0.01  
   
 
 
 
 
      Total basic EPS   $ 0.33   $ 0.03   $ 1.44   $ (0.04 )
   
 
 
 
 
 
Diluted EPS from continuing operations

 

$

0.33

 

$

0.02

 

$

1.19

 

$

(0.05

)
  Diluted EPS from discontinued operations     (0.01 )   0.01     0.21     0.01  
   
 
 
 
 
      Total diluted EPS   $ 0.32   $ 0.03   $ 1.40   $ (0.04 )
   
 
 
 
 

See Notes to Interim Consolidated Financial Statements.

5



COBALT CORPORATION
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME (LOSS)
(UNAUDITED)

 
  Number of
Common Shares

  Common
Stock

  Retained
Earnings
(Deficit)

  Accumulated Other
Comprehensive
Income (Loss)

  Total
Shareholders'
Equity

 
 
  (In thousands, except share data)

 
Balance at December 31, 2000     $   $ 170,907   $ (1,964 ) $ 168,943  
  Capitalization of Wisconsin United for Health Foundation, Inc.   31,313,390     192,577     (192,577 )        
  Issuance of common stock—acquisition   9,096,303     55,938             55,938  
  Issuance of common stock—options   11,250     51             51  
  Issuance of common stock—401(k)   172,100     1,000             1,000  
  Adjustments as a result of purchase accounting           82         82  
  Change in ownership of affiliates           1,320         1,320  
  Conversion of SAR's to options           594         594  
  Comprehensive loss:                              
    Net loss           (22,305 )       (22,305 )
    Change in unrealized gains/losses on investments, net of tax               2,599     2,599  
                         
 
      Comprehensive loss                           (19,706 )
   
 
 
 
 
 
Balance at December 31, 2001   40,593,043   $ 249,566   $ (41,979 ) $ 635   $ 208,222  
  Issuance of common stock—options   845,946     9,293             9,293  
  Issuance of common stock—401(k)   64,880     450             450  
  Change in ownership of affiliates           1,304         1,304  
  Compensation expense—stock options           134         134  
  Comprehensive income:                              
    Net income           58,832         58,832  
    Change in unrealized gains/losses on investments, net of tax               7,029     7,029  
                         
 
      Comprehensive income                           65,861  
   
 
 
 
 
 
Balance at September 30, 2002   41,503,869   $ 259,309   $ 18,291   $ 7,664   $ 285,264  
   
 
 
 
 
 

See Notes to Interim Consolidated Financial Statements.

6



COBALT CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)

 
  Nine months ended
September 30,

 
 
  2002
  2001
 
 
  (In thousands)

 
Operating activities:              
  Income (loss) from continuing operations   $ 49,894   $ (1,954 )
  Adjustments to reconcile income (loss) from continuing operations to net cash provided by (used in) operating activities:              
    Depreciation and amortization     8,745     12,398  
    Income from investment in affiliates, net of tax     (15,320 )   (388 )
    Realized investment gains, net     (207 )   (380 )
    Deferred income taxes     (3,715 )   199  
    Changes in operating accounts, net of discontinued operations, acquisitions and conversion/combination related activity:              
      Premium receivables     (3,888 )   8,142  
      Other receivables     (2,061 )   (7,187 )
      Due from clinics and providers     7,703     5,064  
      Medical and other benefits payable     (17,657 )   (6,183 )
      Advance premiums     12,074     76  
      Due to/from affiliates, net     (1,350 )   (10,305 )
      Other, net     (1,154 )   410  
   
 
 
        Net cash provided by (used in) continuing operations     33,064     (108 )

Investing activities:

 

 

 

 

 

 

 
  Acquisitions and Combination activity         48,242  
  Proceeds from sale of investment in affiliate     68,436      
  Proceeds from sale of discontinued operations     17,000      
  Purchases of available-for-sale investments     (180,983 )   (95,787 )
  Purchases of held-to-maturity investments     (5,546 )   (1,300 )
  Proceeds from maturity of held-to-maturity investments     3,755     250  
  Proceeds from sale and maturity of available-for-sale investments     63,119     84,690  
  Additions to property and equipment, net     (7,860 )   (3,427 )
  Dividends from affiliate     552      
   
 
 
        Net cash provided by (used in) investing activities     (41,527 )   32,668  

Financing activities:

 

 

 

 

 

 

 
  Proceeds from issuance of common stock     6,568     480  
  Net borrowings of debt     13,056     3,181  
   
 
 
        Net cash provided by financing activities     19,624     3,661  

Discontinued Operations:

 

 

 

 

 

 

 
  Cash flows from discontinued operations     349     46  
   
 
 
        Net cash provided by discontinued operations     349     46  

Cash and cash equivalents:

 

 

 

 

 

 

 
  Increase during the period     11,510     36,267  
  Balance at beginning of year     51,669     1,305  
   
 
 
        Balance at end of period   $ 63,179   $ 37,572  
   
 
 

See Notes to Interim Consolidated Financial Statements.

7



COBALT CORPORATION
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

Note A. Basis of Presentation

        The accompanying unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States ("GAAP") for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2002 are not necessarily indicative of the results that may be expected for the year ending December 31, 2002. These interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2001 and footnotes thereto included in the Cobalt Corporation ("Cobalt" or the "Company") Annual Report on Form 10-K for the year ended December 31, 2001, as filed with the Securities and Exchange Commission ("SEC").

        Cobalt (formerly known as United Wisconsin Services, Inc. ("UWS")) was created as a result of the combination of UWS and Blue Cross & Blue Shield United of Wisconsin ("BCBSUW") on March 23, 2001 (the "Combination"). On that date, BCBSUW converted from a service insurance corporation to a stockholder owned corporation. Upon conversion, BCBSUW became a wholly-owned subsidiary of UWS through the combination of the two companies. At the time of conversion and the Combination, BCBSUW owned approximately 46.6% of UWS' outstanding common stock. In exchange for the ownership of BCBSUW, Cobalt issued 31,313,390 shares of newly issued Company common stock to Wisconsin United for Health Foundation, Inc. (the "Foundation"). The Foundation was established for the sole purpose of benefiting public health in Wisconsin from its earnings and investment in Cobalt.

        The Combination was accounted for as a purchase by BCBSUW of the remaining 9,096,303 shares of UWS that it did not already own at a market price of $6.15 per share on the closing date. In accordance with GAAP, goodwill was recorded representing the excess of the market price over the adjusted book value of UWS for the 53.4% of UWS that BCBSUW did not already own. For reporting purposes, the Combination is treated as a reverse purchase transaction, whereby BCBSUW becomes the acquirer and reporting entity for public company reporting. The consolidated statements of operations, cash flows, and changes in shareholders' equity and comprehensive income (loss) for the three and nine month periods ended September 30, 2002 reflect the operations of the combined UWS and BCBSUW entities. Results for the three month period ended March 31, 2001, which are reflected in the consolidated financial statements for the nine months ended September 30, 2001, include only the operations of BCBSUW and its wholly-owned subsidiary, Government Health Services, LLC ("GHS") and minority interest in UWS and American Medical Security Group, Inc. ("AMSG"). GHS is a holding company that was recently formed to hold United Government Services, LLC ("UGS") and Trust Solutions, LLC ("TS"). TS provides program integrity, consulting and safeguard services in connection with publicly funded health programs. Results for the six month period ended September 30, 2001, included in the consolidated financial statements for the nine months ended September 30, 2001, reflect the operations of the combined UWS and BCBSUW entities. For purposes of calculating earnings per common share ("EPS") of the Company, the 7,949,904 shares of Cobalt common stock owned by BCBSUW are accounted for as treasury stock. The pro forma statement of operations for the nine months ended September 30, 2001 for Cobalt presented in Note E includes the operations of the former UWS and BCBSUW with elimination of intracompany transactions, the

8



recording of purchase accounting adjustments and the amortization of goodwill calculated as if the transaction was completed at the beginning of the reporting period.

        Continuing operations in the consolidated financial statements subsequent to the Combination include the accounts of the Company's majority owned insurance subsidiaries (BCBSUW, Compcare Health Services Insurance Corporation ("CompcareBlue"), Unity Health Plans Insurance Corporation ("Unity"), Valley Health Plan, Inc. ("Valley"), United Wisconsin Insurance Company ("UWIC"), and United Heartland Life Insurance Company ("UHLIC")) and other non-insurance subsidiaries (GHS, Meridian Resource Company, LLC ("MRC"), Comprehensive Receivables Group, Inc. ("CRG"), United Wisconsin Proservices, Inc. ("Proservices"), United Heartland, Inc. ("UHI") and C.C. Holdings, LLC ("CC Holdings")). All intracompany transactions after March 31, 2001 have been eliminated in consolidation.

Note B. Management's Plan

        In order to assure the Company's regulated insurance subsidiaries continue to satisfy minimum capital and liquidity requirements, the Office of the Commissioner of Insurance of the State of Wisconsin ("OCI") requested, management developed and the Cobalt Board of Directors approved a capital plan at the end of 2001 to improve the Company's position relative to minimum capital and liquidity requirements. In October 2002, the Company received approval from the OCI and satisfied the $70.0 million obligation due BCBSUW from Cobalt. The debt obligation under the note was satisfied in full through the transfer of all of the common stock of CompcareBlue. With this transaction, the Company has substantially completed all aspects of the capital plan. See "Management's Discussion and Analysis of Financial Condition and Results of Operations" for further discussion on the capital plan.

Note C. Discontinued Operations

        On March 29, 2002, Cobalt sold 100% of the membership interest of its subsidiary, Innovative Resource Group, LLC ("IRG") to APS Healthcare Bethesda, Inc. ("APS"), for $27.0 million ($17.0 million in cash and $10.0 million in a three-year note. The $10.0 million note was discounted to $8.5 million to yield 16% per year). IRG was one of Cobalt's specialty companies, which provided behavioral health and medical management services. Accordingly, IRG is accounted for as a discontinued operation for all periods presented. The purchase agreement also provides for certain bonuses/penalties to be received/paid between IRG and Cobalt based on revenues generated from Cobalt and affiliated entities in future years. Under the agreement, certain subsidiaries of Cobalt entered into seven-year service agreements for the provision of services by IRG.

        The net gain on disposition of discontinued operations was $8.9 million, which includes a realized gain on the sale of $9.6 million, offset by a $0.7 million loss on IRG's operations for the nine months ended September 30, 2002. The realized gain on the sale as of September 30, 2002 reflects additional tax expense of $0.2 million recorded during the third quarter of 2002. The net gain on the sale could be adjusted further, based on any payments made in future periods in accordance with the purchase and sale agreement. Income from discontinued operations amounted to $0.4 million and $0.5 million for the three and nine month periods ended September 30, 2001, respectively. This reflects activity for the second and third quarters of 2001 only, since IRG was not considered part of Cobalt for financial reporting purposes prior to the Combination.

9



Note D. Net Income (Loss) Per Share

 
  Three months ended
September 30,

  Nine months ended
September 30,

 
 
  2002
  2001
  2002
  2001
 
Numerator (in thousands):                          
  Net income (loss)   $ 13,717   $ 1,057   $ 58,832   $ (1,455 )
   
 
 
 
 
Denominator:                          
  Denominator for basic EPS—Weighted average shares     41,272,729     40,438,098     40,940,305     37,722,313  
  Effect of dilutive securities—Employee stock options     1,352,574     220,200     1,150,736